Home / News / World News / Article /
US FDA approves updated Covid-19 vaccines for 2026-27 immunisation season
Updated On: 28 August, 2026 10:31 AM IST | Washington | mid-day online correspondent
The US FDA has approved updated Covid-19 vaccines from Moderna, Pfizer-BioNTech and Novavax-Sanofi for the 2026-27 immunisation season. The shots are approved for people aged 65 and older and younger high-risk individuals, with age eligibility varying by vaccine

US FDA approves updated Covid vaccines (File pic)
The US Food and Drug Administration (FDA) approved the updated Covid-19 vaccines on Thursday, August 27. The approval from the FDA will allow manufacturers to begin shipping doses to pharmacies and doctors’ offices across the country.
Food and drug regulators have approved Moderna, Novavax-Sanofi and Pfizer-BioNTech’s updated Covid vaccines, the companies said on Thursday. Their statement comes after an advisory panel recommended that the shots should target the dominant XFG variant.
Trending Stories
ADVERTISEMENT
ADVERTISEMENT


